SCARDA Now Up and Running: Will It Lead to a Recovery in Japan’s Ability to Develop Vaccines?

The Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) was established as Japan’s vaccine R&D control tower within the Japan Agency for Medical Research and Development (AMED) on March 22. To prepare for infectious...read more